Calidi Biotherapeutics, Inc. (CLDI)

Operating Cash Flow (Statement)

-$17.75M

TTM · Period ending: · USD

CLDI logo

CLDI Operating Cash Flow (Statement)

Latest reported-$17.75M
CLDI TTM Cash from Operations (-$9.28M → -$17.75M)
High-resolution chart · PNG

CLDI operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Calidi Biotherapeutics, Inc. Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-17,750,999
-18,277,999
-21,293,000
-21,672,000
-22,380,000
-21,331,000
-18,031,000
-17,794,000
-26,365,000
-27,707,000
-26,983,000
-25,673,000
-20,760,190
-18,544,190
-17,543,190
-16,412,190
-9,277,529
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.